Meta-Analysis
Copyright ©The Author(s) 2018.
World J Cardiol. Jun 26, 2018; 10(6): 41-48
Published online Jun 26, 2018. doi: 10.4330/wjc.v10.i6.41
Table 1 Baseline characteristics
VariablesTreatment groupsCLOSE(mean ± SD) or NCLOSURE I(mean ± SD) or NPC(mean ± SD) or NREDUCE(mean ± SD) or NRESPECT(mean ± SD) or N
Age (yr)PFO Closure42.9 ± 10.146.3 ± 9.644.3 ± 10.245.4 ± 9.345.7 ± 9.7
Medical therapy43.8 ± 10.545.7 ± 9.144.6 ± 10.144.8 ± 9.646.2 ± 10
Age range (yr)PFO Closure16-6018-60< 6018-5918-60
Medical therapy16-6018-60< 6018-5918-60
MalePFO Closure13723392261268
Medical therapy142238114138268
SmokerPFO Closure6896526375
Medical therapy69104472555
HypertensionPFO Closure2715149112160
Medical therapy241315858163
HyperPFO Closure3021250-196
lipidemiaMedical therapy3618962-195
Diabetes mellitusPFO Closure3-51833
Medical therapy9-61041
CADPFO Closure-64-19
Medical therapy-44-9
Family hx of CAD or strokePFO Closure-24753-136
Medical therapy-25740-109
CHFPFO Closure-2-3
Medical therapy-0-0
MIPFO Closure073-5
Medical therapy051-2
Cardiac catheterizationPFO Closure-23---
Medical therapy-17---
Valvular diseasePFO Closure-498--
Medical therapy-455--
ArrhythmiaPFO Closure-26---
Medical therapy-19---
PTCAPFO Closure-6---
Medical therapy-2---
PVDPFO Closure-53-5
Medical therapy-72-1
Stokes-adams syndromePFO Closure-4---
Medical therapy-3---
DVT or PEPFO Closure50---
Medical therapy44---
MigrainePFO Closure67-47-195
Medical therapy78-38-186
PericarditisPFO Closure-2---
Medical therapy-3---
CardioPFO Closure-1---
myopathyMedical therapy-0---
Index cryptogenic strokePFO Closure238324165441-
Medical therapy235329163223-
Index TIAPFO Closure-12233--
Medical therapy-13242--
TEE with moderate- severe shuntPFO Closure-250135348385
Medical therapy-231112173352
Atrial septal aneurysm > 10 mmPFO Closure-1584786180
Medical therapy-16545-169
> 1 previous TIA or strokePFO Closure10-7668111
Medical therapy7-7924112